Conditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function.
The development of an effective vaccine for human immunodeficiency virus type 1 (HIV-1) would be a major advance toward controlling the AIDS pandemic. Several disparate strategies for a safe and effective HIV vaccine have been proposed. Recent data suggest that loss-of-function live-attenuated virus...
Збережено в:
| Опубліковано в:: | Proc Natl Acad Sci U S A |
|---|---|
| Автори: | , , |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
National Academy of Sciences
1996
|
| Предмети: | |
| Онлайн доступ: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC38856/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8755584/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.93.15.7955 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|